You are here

Article info

Article menu
Download PDFPDF
Original Articles
Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer

Authors

  1. Address for correspondence: M.C. Palmer, Department of Medicine, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2.

Citation

PALMER MC, SHEPERT E, SCHEPANSKY A, et al
Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer
International Journal of Gynecologic Cancer 1992;2:301-306.

Publication history

  • First published November 1, 1992.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

International Gynecologic Cancer Society